Blog Category

Tag: Hopen Life Science Ventures

Navigate all the resources featured in the Landscape Guide by geographic location, industry sector, and organization type. Landscape Map
Everything you need to know to make a meaningful first connection can be found in our 2021-22 Landscape Guide! Download the Guide

2022 MVCA Research Report

Our state's entrepreneurial economy hinges on our ability to provide capital to our high-growth, high-potential companies. Download the Report

Upcoming Events

Learn More
September 14 MEMBER NEWS: Beringea invests in record $39.5 million Series C Round for Delphinus Medical Technologies

FARMINGTON HILLS, MICH. (September 10, 2015)— Beringea, a private equity firm providing growth capital to market-leading businesses, is pleased to announce a follow-on investment in Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology.  The company has secured an unprecedented Series C funding round of $39.5 million, the single largest amount ever raised for a […]
Read More
August 04 Member Press Release: Hopen Life Science Ventures Fund II Reaches $25 Million Initial Close and Announces First Four Investments

Fund II is second life science fund managed by West Michigan-based Hopen Life Science Ventures Grand Rapids, Mich.– Hopen Life Science Ventures, a Grand Rapids-based life science venture capital fund, announced an initial close of $25 million for its second fund, Hopen Life Science Fund II.  The fund will remain open to new limited partners […]
Read More
February 20 Hopen Life Science Ventures’ Expert Team Committed to Creating Culture of Innovation in Michigan

Between its two funds, Hopen manages more than $65 million, which it prefers to invest in the region.

Read More
April 24 ProNAi Therapeutics Raises $59.5M Series D Round for Phase II Clinical Trials

ProNAi Therapeutics Inc . has collected $59.5 million after clinical studies showed that its lead drug could help non-Hodgkin’s lymphoma patients who are running out of options.
Read More